Risk Factors And Surgical Outcomes Of Strabismus Reoperation (RSOR)

March 6, 2026 updated by: Rehab Safwat Hamza, Assiut University

Risk Factors And Surgical Outcomes Of Strabismus Reoperation: A Clinical Study

Horizontal strabismus, commonly known as inward or outward deviation of the eyes, is a frequent eye condition that may require surgical correction. Although the first surgery is often successful, some patients develop residual or recurrent eye misalignment and require a second operation (reoperation).

This study aims to identify the clinical and surgical factors that may increase the risk of undercorrection, overcorrection, or recurrence after the first surgery. It also evaluates the outcomes and success rate of repeat surgery in patients with horizontal strabismus.

Patients undergoing reoperation will receive a complete ophthalmological examination before surgery. The surgical plan will be individualized based on previous surgical history and current eye findings. All procedures will be performed under general anesthesia by the same surgeon. Participants will be followed for three months after surgery to assess eye alignment, movement, and possible complications.

The results of this study may help improve surgical planning and predict which patients are at higher risk of requiring additional surgery in the future.

Study Overview

Status

Not yet recruiting

Detailed Description

Horizontal strabismus, including esotropia and exotropia, represents the most common form of ocular misalignment requiring surgical intervention. Despite advances in surgical techniques, a proportion of patients experience residual deviation, overcorrection, or recurrence after primary surgery, necessitating reoperation. Reoperation presents unique surgical challenges due to altered anatomy, scar tissue formation, possible muscle slippage, and variability in postoperative healing response.

Reported reoperation rates vary across studies and clinical settings, with multiple patient-related and surgical factors implicated in surgical failure. These factors may include age at primary surgery, magnitude of deviation, amblyopia, number of operated muscles, surgical technique, and time interval between surgeries. However, data regarding predictive risk factors and standardized outcome evaluation in reoperated horizontal strabismus remain limited in the local setting.

This prospective interventional study will be conducted at Assiut University Hospital. It will include patients undergoing repeat surgery for correction of horizontal strabismus. Patients with vertical deviations, paralytic or restrictive strabismus, neurological or syndromic associations, or incomplete previous surgical data will be excluded.

Preoperative assessment will include measurement of visual acuity, cycloplegic refraction, anterior and posterior segment examination, evaluation of ocular motility in nine diagnostic positions of gaze, and measurement of angle of deviation using prism and alternate cover test or Krimsky test when appropriate. Documentation of conjunctival scarring and previous surgical details will be performed.

The surgical approach will be individualized according to preoperative findings and prior operative records. Exploration of previously operated muscles will be performed when clinically indicated. Intraoperative forced duction testing will assess muscle tightness. All surgeries will be conducted under general anesthesia by the same surgeon to reduce inter-operator variability.

Participants will be followed postoperatively at 1 day, 1 week, 1 month, and 3 months. Surgical success will be defined as postoperative alignment within ±10 prism diopters of orthotropia at final follow-up. Secondary outcomes include stability of alignment and postoperative complications such as limitation of ocular motility or conjunctival scarring.

Statistical analysis will evaluate associations between demographic and clinical variables and surgical outcomes using multivariate regression to identify independent risk factors for reoperation outcomes.

The findings of this study aim to improve risk stratification, optimize surgical planning, and enhance long-term outcomes in patients undergoing horizontal strabismus reoperation.

Study Type

Interventional

Enrollment (Estimated)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Asyut, Egypt
        • Assiut University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with horizontal strabismus (esotropia or exotropia).

    • Patients undergoing repeat surgery for correction of residual, recurrent, undercorrected, or overcorrected horizontal strabismus.
    • Availability of sufficient medical records documenting previous strabismus surgery.
    • Ability to attend scheduled postoperative follow-up visits.
    • Written informed consent obtained from the patient or legal guardian.

Exclusion Criteria:

  • Combined vertical and horizontal strabismus.

    • Paralytic strabismus.
    • Restrictive strabismus.
    • Strabismus associated with neurological or syndromic conditions.
    • Patients with incomplete or insufficient documentation of previous surgical procedures.
    • Patients unwilling or unable to complete follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Horizontal Strabismus Reoperation
All enrolled participants undergo repeat surgery for correction of horizontal strabismus (esotropia or exotropia). The surgical approach is individualized based on preoperative clinical evaluation and prior operative records. Exploration of previously operated muscles is performed when indicated, particularly in cases of limited ocular motility or suspected scarring. Otherwise, surgery is performed on unoperated horizontal rectus muscles when appropriate. Intraoperative forced duction testing is conducted to assess muscle tightness, and scar tissue release is performed if necessary. All procedures are performed under general anesthesia by the same surgeon. Participants are followed postoperatively to evaluate alignment, ocular motility, and surgical outcomes.
Horizontal strabismus reoperation is performed to correct residual or recurrent esotropia or exotropia following previous strabismus surgery. The surgical plan is individualized based on preoperative assessment and prior operative records. Previously operated muscles are explored when limited ocular motility, scarring, or suspected muscle slippage is present. In other cases, surgery may be performed on unoperated horizontal rectus muscles when appropriate. Intraoperative forced duction testing is conducted to assess muscle tightness, and scar tissue is released when indicated. All procedures are performed under general anesthesia by the same surgeon. Postoperative alignment and ocular motility are evaluated during follow-up visits.
Other Names:
  • Strabismus Reoperation
  • Repeat Strabismus Surgery
  • Horizontal Rectus Muscle Reoperation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate Of Surgical Success After Horizontal Strabismus Reoperation
Time Frame: 3 months postoperative
Percentage of participants achieving postoperative ocular alignment within ±10 prism diopters of orthotropia measured using the Prism and Alternate Cover Test at distance fixation.
3 months postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preoperative Angle Of Deviation
Time Frame: Baseline (preoperative)
Angle of ocular deviation measured in prism diopters using the Prism and Alternate Cover Test at distance fixation before surgery.
Baseline (preoperative)
Age At Primary Strabismus Surgery
Time Frame: Baseline
Age of the participant at the time of initial strabismus surgery obtained from medical records.
Baseline
Presence Of Amblyopia
Time Frame: Baseline
Presence of amblyopia determined by best corrected visual acuity assessment during preoperative evaluation.
Baseline
Number Of Extraocular Muscles Operated During Reoperation
Time Frame: Intraoperative
Number of horizontal rectus muscles surgically operated during the reoperation procedure.
Intraoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Rajavi Z, Gozin M, Sabbaghi H, et al. Reoperation in horizontal strabismus and its related risk factors. Med Hypothesis Discov Innov Ophthalmol. 2018;7(2):73-82.
  • Heo H, Park H, Kim J, Lee S. Effect of age on reoperation rate in children undergoing exotropia surgery. Acta Ophthalmol. 2021;101(3):e412-e416.
  • Yetkin AA. Factors affecting surgical success rates in pediatric horizontal strabismus surgery: deviation angle and amblyopia. Cureus. 2024;16(5):e12345.
  • Akbari MR. Preoperative factors associated with multiple strabismus surgeries: a large retrospective database study. Optom Vis Sci. 2026;103(1):45-52.
  • Olitsky SE, Coats DK. Complications of strabismus surgery: incidence and risk factors. Middle East Afr J Ophthalmol. 2015;22(3):320-332.
  • Niu R, Zhang J, Chen X, Li Y, Wang L. Comprehensive analysis of strabismus reoperations: clinical insights and recurrence after primary correction. BMC Ophthalmol. 2024;24:446. doi:10.1186/s12886-024-03712-2.
  • Samplaski MK. Editorial Commentary. Urol Pract. 2019 Jan;6(1):44. doi: 10.1097/01.UPJ.0000552857.40544.a1. Epub 2018 Dec 27. No abstract available.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

February 24, 2026

First Submitted That Met QC Criteria

February 27, 2026

First Posted (Actual)

March 3, 2026

Study Record Updates

Last Update Posted (Actual)

March 9, 2026

Last Update Submitted That Met QC Criteria

March 6, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Strabismus

Clinical Trials on Horizontal Strabismus Reoperation

Subscribe